These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 36350420
1. The significance of EphA2-regulated Wnt/β-catenin signal pathway in promoting the metastasis of HBV-related hepatocellular carcinoma. Wang Y, Zhang Z, Zhu Z, Wang P, Zhang J, Liu H, Li J. Mol Biol Rep; 2023 Jan; 50(1):565-575. PubMed ID: 36350420 [Abstract] [Full Text] [Related]
2. HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway. Chen Z, Tang J, Cai X, Huang Y, Gao Q, Liang L, Tian L, Yang Y, Zheng Y, Hu Y, Tang N. Cancer Sci; 2016 Oct; 107(10):1380-1389. PubMed ID: 27420729 [Abstract] [Full Text] [Related]
3. miR-557 inhibits hepatocellular carcinoma progression through Wnt/β-catenin signaling pathway by targeting RAB10. Cheng X, Wu C, Xu H, Zou R, Li T, Ye S. Aging (Albany NY); 2024 Feb 15; 16(4):3716-3733. PubMed ID: 38364252 [Abstract] [Full Text] [Related]
4. A novel O2- (2,4-dinitrophenyl) diazeniumdiolate inhibits hepatocellular carcinoma migration, invasion, and EMT through the Wnt/β-catenin pathway. Xing Y, Hu Y, Zou H, Xie H, Jiang T, Liu L. Toxicol In Vitro; 2022 Oct 15; 84():105456. PubMed ID: 35985571 [Abstract] [Full Text] [Related]
5. MicroRNA-338 inhibits proliferation, migration, and invasion of gastric cancer cells by the Wnt/β-catenin signaling pathway. Song B, Lin HX, Dong LL, Ma JJ, Jiang ZG. Eur Rev Med Pharmacol Sci; 2018 Mar 15; 22(5):1290-1296. PubMed ID: 29565486 [Abstract] [Full Text] [Related]
6. ADAMDEC1 induces EMT and promotes colorectal cancer cells metastasis by enhancing Wnt/β-catenin signaling via negative modulation of GSK-3β. Jia Y, Huang X, Shi H, Wang M, Chen J, Zhang H, Hou D, Jing H, Du J, Han H, Zhang J. Exp Cell Res; 2023 Aug 15; 429(2):113629. PubMed ID: 37187249 [Abstract] [Full Text] [Related]
7. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling. Zhao YR, Wang JL, Xu C, Li YM, Sun B, Yang LY. Clin Sci (Lond); 2019 Jul 31; 133(14):1645-1662. PubMed ID: 31278131 [Abstract] [Full Text] [Related]
8. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling. Zhao G, Song Y, Dong L, Shi H, Li H, Yang L, Wang J. Biochem Biophys Res Commun; 2019 Oct 01; 517(4):722-728. PubMed ID: 31395338 [Abstract] [Full Text] [Related]
9. MicroRNA-582-3p targeting ribonucleotide reductase regulatory subunit M2 inhibits the tumorigenesis of hepatocellular carcinoma by regulating the Wnt/β-catenin signaling pathway. Xu H, Li B. Bioengineered; 2022 May 01; 13(5):12876-12887. PubMed ID: 35609318 [Abstract] [Full Text] [Related]
10. Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway. Qin CD, Ma DN, Ren ZG, Zhu XD, Wang CH, Wang YC, Ye BG, Cao MQ, Gao DM, Tang ZY. Oncol Rep; 2017 Mar 01; 37(3):1725-1735. PubMed ID: 28112375 [Abstract] [Full Text] [Related]
11. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway. Lei T, Zhu X, Zhu K, Jia F, Li S. Cancer Biol Ther; 2019 Mar 01; 20(7):1007-1016. PubMed ID: 30929558 [Abstract] [Full Text] [Related]
12. Sirtuin 2 Isoform 1 Enhances Hepatitis B Virus RNA Transcription and DNA Synthesis through the AKT/GSK-3β/β-Catenin Signaling Pathway. Piracha ZZ, Kwon H, Saeed U, Kim J, Jung J, Chwae YJ, Park S, Shin HJ, Kim K. J Virol; 2018 Nov 01; 92(21):. PubMed ID: 30111572 [Abstract] [Full Text] [Related]
13. USP25 promotes hepatocellular carcinoma progression by interacting with TRIM21 via the Wnt/β-catenin signaling pathway. Liu Y, Ma J, Lu S, He P, Dong W. Chin Med J (Engl); 2023 Sep 20; 136(18):2229-2242. PubMed ID: 37439386 [Abstract] [Full Text] [Related]
14. Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells. Park NR, Cha JH, Jang JW, Bae SH, Jang B, Kim JH, Hur W, Choi JY, Yoon SK. Biochem Biophys Res Commun; 2016 Sep 02; 477(4):568-574. PubMed ID: 27320862 [Abstract] [Full Text] [Related]
15. Silencing MFN2 Drives WNT/β-catenin Nucleation to Reduce Sorafenib Sensitivity in Hepatocellular Carcinoma Cells. Zeng CM, Shao B, Chen YP, Ding GS. Curr Med Sci; 2024 Aug 02; 44(4):789-798. PubMed ID: 38926329 [Abstract] [Full Text] [Related]
16. EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells. Huang J, Xiao D, Li G, Ma J, Chen P, Yuan W, Hou F, Ge J, Zhong M, Tang Y, Xia X, Chen Z. Oncogene; 2014 May 22; 33(21):2737-47. PubMed ID: 23752181 [Abstract] [Full Text] [Related]
17. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β-catenin and TGF-β/EMT signaling pathways. Liu Z, Zhang Y, Xu Z. J BUON; 2018 May 22; 23(1):185-187. PubMed ID: 29552781 [Abstract] [Full Text] [Related]
18. Forkhead box (FOX) G1 promotes hepatocellular carcinoma epithelial-Mesenchymal transition by activating Wnt signal through forming T-cell factor-4/Beta-catenin/FOXG1 complex. Zheng X, Lin J, Wu H, Mo Z, Lian Y, Wang P, Hu Z, Gao Z, Peng L, Xie C. J Exp Clin Cancer Res; 2019 Nov 27; 38(1):475. PubMed ID: 31771611 [Abstract] [Full Text] [Related]
19. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway. Xie Q, Chen L, Shan X, Shan X, Tang J, Zhou F, Chen Q, Quan H, Nie D, Zhang W, Huang AL, Tang N. Int J Cancer; 2014 Aug 01; 135(3):635-46. PubMed ID: 24374650 [Abstract] [Full Text] [Related]
20. FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3β/β- catenin signaling cascade via FGFR4 activation. Zhao H, Lv F, Liang G, Huang X, Wu G, Zhang W, Yu L, Shi L, Teng Y. Oncotarget; 2016 Mar 22; 7(12):13575-86. PubMed ID: 26498355 [Abstract] [Full Text] [Related] Page: [Next] [New Search]